| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |